« Big Pharma Herd: Diversify, It's the Wave of the Future | Main | Immune Design Receives $212 M Boost from Adjuvant Deal »

10/28/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b013488878cbd970c

Listed below are links to weblogs that reference Roche Breaks from the Herd:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

More from Sev Schwann on Roche's plans for competing versus biosimilar competitors as patents begin to expire
http://online.wsj.com/article/SB10001424052702304354104575568333806179778.html?mod=googlenews_wsj

k

IIRC, Roche owns Sandoz, which is its generic line (like Roxane is Boehringer Ingelheim's generic line). Roche has facilities in Broomfield CO and bought neighboring generic manufacturer Geneva Labs, which is now Sandoz.

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada